Additional lineage-specific DC alterations in severe COVID-19 included down-regulation of IL-6R in DC1 and a drastic decrease of the inhibitory receptor CD200R in the cDC2 lineage, including circulating progenitors. The gene discussed is IL6R; the disease is COVID-19.